Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal contracts (SAM.gov)The Ultimate Guide to SAM.gov Registration
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›Q301 Histocompatibility Transplant Testing and…

U.S. Department Of Veterans Affairs·Washington

Q301 Histocompatibility Transplant Testing and Interpretation

Closes 2/27/2026$1k – $9M
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The Department of Veterans Affairs, Veterans Healthcare Administration, Regional Procurement Office West, Network Contracting Office 20, is seeking a contractor to provide histocompatibility and immunogenetics testing and interpretation services to support the VA Portland Health Care System's transplant program. The contract will be for a period of five years, with a minimum guarantee of $1,000 and a total capacity of $9,000,000. The contractor will be required to provide testing and interpretation services for the VA Portland Health Care System, and the contract will include five ordering periods. • The contractor must have experience in histocompatibility and immunogenetics testing and interpretation. • The contractor must be able to provide testing and interpretation services for the VA Portland Health Care System. • The contractor must be able to meet the minimum guarantee of $1,000 and the total capacity of $9,000,000. • The contractor must be able to provide services for the five ordering periods. • The contractor must comply with all applicable Federal, State, and local laws, executive orders, rules, and regulations.

Attached files

Contact

Eric Lingenfelter(Contracting Specialist)

[email protected]

(360) 852-9891

Key dates

Opened
2/4/2026
Closes
2/27/2026
Duration
60 months

Last updated

Details

Industry
Healthcare and Medical Services
NAICS
621511
Solicitation №
36C26026Q0245_1

Budget estimate

$1,000 – $9,000,000

Based on the provided information, the budget for this opportunity is estimated to be between $1,000 and $9,000,000 over the course of five years, with the actual budget depending on the number and type of tests performed. This estimate is based on the minimum guarantee and total capacity mentioned in the document. The factors that may influence the likely payment range include the volume of tests required by the VA Portland Health Care System, the complexity of the tests, and the contractor's ability to meet the minimum guarantee and total capacity.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. Department Of Veterans Affairs·Illinois

Top match · 72%

Q301--Blood Donor Panel Testing for Captain James A. Lovell Federal Health Care Center (FHCC)

Closes 11/3/2026Opened 10/27/2026

U.S. National Institutes of Health·United States of America

67% match

Translational Transplantation Tolerance Cooperative Study Group

Closes 5/20/2027Opened 6/24/2026

U.S. Department Of Veterans Affairs·New Jersey

66% match

Q301--Reference and Esoteric Laboratory Testing

Closes 11/30/2026Opened 10/30/2026

U.S. National Institutes of Health·United States of America

65% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: Tissue Procurement Center (R24 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. National Institutes of Health·United States of America

64% match

Clinical Trials in Organ Transplantation in Children and Adults

Closes 9/29/2027Opened 6/24/2026

U.S. National Institutes of Health·United States of America

64% match

Screening and Functional Validation of Genomic Variants Associated with Human Congenital Anomalies (R01 Clinical Trial Not Allowed)

Closes 1/7/2028Opened 10/30/2024

U.S. National Institutes of Health·United States of America

63% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: Experimental and Computational Technology Development (RM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. National Institutes of Health·United States of America

63% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: National Somatic Mosaicism Commons Data Analysis & Organizational Center (UM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. National Institutes of Health·United States of America

63% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: Genome Characterization Centers (UM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. National Institutes of Health·United States of America

62% match

Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)

Closes 1/29/2027Opened 6/24/2026

U.S. National Institutes of Health·United States of America

62% match

Systematic Characterization of Genomic Variation to Assess Effects of Individual Variants on Genome Function and Phenotype (UM1 Clinical Trials Not Allowed)

Closes 12/14/2026Opened 5/12/2025

U.S. National Institutes of Health·United States of America

62% match

Computational Modeling and Analysis of the Impact of Genomic Variation on Function (UM1, Clinical Trial Not Allowed)

Closes 12/14/2026Opened 6/6/2025

U.S. National Institutes of Health·United States of America

61% match

Testing Centers for Evaluation of Somatic Cell Genome Editing Approaches for Translational Applications (U42 Clinical Trial Not Allowed)

Closes 1/24/2028Opened 10/13/2026

U.S. National Institutes of Health·United States of America

61% match

Immune Tolerance Network (UM1 Clinical Trial Required)

Closes 1/29/2027Opened 6/24/2026

LA County Sheriff·California

61% match

RFSQ - DNA Laboratory Services

Rolling / TBD closeOpened 11/9/2021

Mental Health, NYS Office of·New York

61% match

IFB 26-067 FLU/PCR, CT/NG PCR and HCV/PCR Testing

Closes 12/3/2026Opened 10/16/2026

U.S. National Institutes of Health·United States of America

61% match

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Closes 11/10/2026Opened 9/8/2025

U.S. Defense Health Agency Contracting Activity - DHACA·United States of America

61% match

DoW Reconstructive Transplant, Investigator-Initiated Research Award

Closes 11/4/2026Opened 8/4/2026

Massachusetts Department of Public Health·Massachusetts

61% match

RFR 224330 Anatomic Pathology Laboratory Services

Closes 9/1/2030Opened 8/18/2021

U.S. National Institutes of Health·United States of America

61% match

INCLUDE Project: Omics Phenotypes Related to Down Syndrome (X01 Clinical Trial Not Allowed)

Closes 6/14/2027Opened 7/28/2026

U.S. Department Of Health And Human Services·District of Columbia

61% match

Brain Repair of Any Injured Neural Structure (BRAINS)

Closes 2/26/2027Opened 7/2/2026

Louisiana Jefferson Parish·Louisiana

61% match

PROVIDE SPECIMEN COLLECTION AND TESTING OF FORENSIC SAMPLES PROVIDED B

Closes 11/10/2026Opened 10/7/2026

U.S. National Institutes of Health·United States of America

61% match

NIDDK Disease Research and Translational Core Centers (P30 Clinical Trial Optional)

Closes 5/31/2027Opened 7/2/2026

U.S. National Institutes of Health·United States of America

60% match

Improved Drug Susceptibility Testing (DST) for Mycobacteria

Closes 5/27/2027Opened 6/24/2026

U.S. National Institutes of Health·United States of America

60% match

Accelerating Discovery through Partnered Research with All of Us to Analyze Participant Biospecimens (X01 Clinical Trial Not Allowed)

Closes 3/1/2027Opened 1/8/2026